Which statement best describes riboflavin therapy in migraine prevention?

Prepare for the Pharmacology IV – Headache Therapeutics Test. Review the therapeutic approaches, tackle multiple-choice questions with explanations, and boost your test-taking confidence. Ace your exam with precision!

Multiple Choice

Which statement best describes riboflavin therapy in migraine prevention?

Riboflavin therapy for migraine prevention is characterized by a favorable safety profile and good tolerability. When given in high daily doses (around 400 mg), it is generally well tolerated with few and mild adverse effects. The most common notable effect is harmless yellow-orange urine from excreted vitamin B2; occasional mild GI upset can occur, but serious adverse effects are rare. Its safety, low risk of interactions, and low cost contribute to it being a preferred preventive option for many patients. This makes the statement that it is well tolerated the best description.

Riboflavin therapy for migraine prevention is characterized by a favorable safety profile and good tolerability. When given in high daily doses (around 400 mg), it is generally well tolerated with few and mild adverse effects. The most common notable effect is harmless yellow-orange urine from excreted vitamin B2; occasional mild GI upset can occur, but serious adverse effects are rare. Its safety, low risk of interactions, and low cost contribute to it being a preferred preventive option for many patients. This makes the statement that it is well tolerated the best description.

More practice questions